FerGene is a new gene therapy company dedicated to creating and delivering innovative solutions to urologists and those affected by non-muscle invasive bladder cancer (NMIBC). Our goal is to provide greater hope to patients with this disease, who have seen little improvement in their standard of care over the past 20 years. FerGene, Inc. is a privately held company, created through a joint partnership between Ferring Pharmaceuticals and Blackstone Life Sciences. With over $570 million in funding, FerGene is preparing to commercialize nadofaragene firadenovec (rAd-IFN/Syn3) for high-grade, BCG-unresponsive NMIBC for the US market. Phase 3 data for nadofaragene firadenovec were presented at the Society of Urologic Oncology Congress in December 2019.
| Website | https://www.fergene.com/ |
| Employees | 1 (1 on RocketReach) |
| Founded | 2020 |
| Address | 245 Main St, Cambridge, Massachusetts 02142, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+14 more
(view full list)
|
| Industry | Biotechnology Research, Clinics/Outpatient Services, Outcome Management (Healthcare) |
| Keywords | Gene Therapy, Novel Therapies, Bladder Cancer, Urology, Cancer Research, Oncology, Cancer Treatment, Immunotherapy, Targeted Therapy, Clinical Trials, Drug Development, Biotechnology, Pharmaceutical, Genetic Engineering, Medical Research, Healthcare, Health Technology, Precision Medicine |
Looking for a particular FerGene employee's phone or email?
FerGene Questions
1 people are employed at FerGene.
FerGene is based in Cambridge, Massachusetts.
Top FerGene Employees
-
Randy Rathburn
Market Development Specialist at FerGene
Portland, OR, US31
